Omega Healthcare Investors (NYSE:OHI) Upgraded to Outperform at BNP Paribas

BNP Paribas upgraded shares of Omega Healthcare Investors (NYSE:OHI - Free Report) from a neutral rating to an outperform rating in a research report sent to investors on Thursday morning, MarketBeat Ratings reports. BNP Paribas currently has $49.00 price objective on the real estate investment trust's stock.

Several other equities research analysts also recently weighed in on the stock. BMO Capital Markets raised their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a "market perform" rating in a research report on Monday, October 7th. Scotiabank raised their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a research report on Monday, August 26th. Berenberg Bank assumed coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They issued a "buy" rating and a $45.00 target price for the company. Truist Financial lifted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a research report on Wednesday, September 4th. Finally, Wells Fargo & Company reaffirmed an "overweight" rating and issued a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $39.70.

Omega Healthcare Investors Stock Down 0.2 %

Shares of NYSE OHI traded down $0.10 on Thursday, reaching $42.43. 2,581,061 shares of the company's stock traded hands, compared to its average volume of 1,647,107. Omega Healthcare Investors has a 12 month low of $27.53 and a 12 month high of $44.42. The business's 50 day simple moving average is $40.34 and its two-hundred day simple moving average is $35.84. The company has a market cap of $10.94 billion, a price-to-earnings ratio of 31.29, a price-to-earnings-growth ratio of 1.34 and a beta of 1.00. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.20). The firm had revenue of $252.70 million for the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. Omega Healthcare Investors's revenue was up 17.5% on a year-over-year basis. During the same period last year, the business earned $0.74 EPS. As a group, equities research analysts forecast that Omega Healthcare Investors will post 2.69 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 6.32%. The ex-dividend date of this dividend is Monday, November 4th. Omega Healthcare Investors's dividend payout ratio is presently 197.06%.

Insider Activity at Omega Healthcare Investors

In related news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Institutional Trading of Omega Healthcare Investors

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. increased its holdings in Omega Healthcare Investors by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust's stock valued at $1,120,478,000 after acquiring an additional 165,105 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Omega Healthcare Investors by 7.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust's stock worth $127,831,000 after buying an additional 272,299 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Omega Healthcare Investors by 4.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust's stock worth $110,971,000 after buying an additional 143,521 shares during the last quarter. LSV Asset Management increased its holdings in shares of Omega Healthcare Investors by 0.7% in the 2nd quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust's stock worth $67,411,000 after buying an additional 14,000 shares during the last quarter. Finally, Daiwa Securities Group Inc. increased its holdings in shares of Omega Healthcare Investors by 1,030.8% in the 2nd quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust's stock worth $32,384,000 after buying an additional 861,907 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.